CClinicalTrials.gg
CompletedNCT07513155Updated Apr 6, 2026

"Retention and Quality of Life in Mandibular Overdentures Using Two Attachment Systems: A Randomized Clinical Trial"

An interventional study of OT-Equator Attachment and Novaloc Attachment in Edentulous Alveolar Ridge In Mandible, Complete Edentulism and Dental Implant, sponsored by Al-Azhar University. Completed at 1 site in Egypt. Open to participants aged 60 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-06.

Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years after the study started (first participant enrolled Apr 2024, registered Apr 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
60 Years to 70 Years
Sex
All
01

Study summary

This randomized clinical trial investigates the effect of two different attachment systems-Equator and Novaloc-on the retention, patient satisfaction, and oral health-related quality of life of mandibular implant overdentures. Completely edentulous patients often experience reduced denture stability, compromised chewing ability, and diminished oral function with conventional complete dentures. Implant-retained overdentures have been shown to improve retention, stability, and overall patient satisfaction. Equator attachments offer a small, resilient, and self-aligning system with variable retention levels, while Novaloc attachments feature innovative PEEK caps and a diamond-like carbon coating designed to reduce wear and maintain long-term retention. This study aims to determine whether one attachment system provides superior functional outcomes and patient-centered benefits, thereby guiding clinicians in optimizing overdenture therapy for edentulous patients."

Read the detailed description

All 26 patients will receive upper complete dentures and lower complete overdentures. The upper complete denture will be mucosa supported and the lower complete denture will be supported and retained for all patients by two dental implants in the inter-foraminal region. Patients will be randomly divided into two equal groups; Group I will be retained by Novaloc attachment. While, Group II will be retained by Equator attachment. Implants will be functionally loaded after three months of insertion.

Retention of lower denture will be measured using digital force gauge, Oral health quality of life will be measured by verbal The Oral Health Impact Profile (OHIP) questionnaire. Patient satisfaction was evaluated with a standard 5-point Liker scale questionnaire. All parameters will be measured at denture insertion, 6 month, and 12 month later.

02

Conditions studied

  • Edentulous Alveolar Ridge In Mandible
  • Complete Edentulism
  • Dental Implant
  • Implant Retained Overdenture
  • Attachment

Keywords

  • Dental Implants
  • Attachments
  • Edentulous Ridge
03

In context

Lead sponsor

Al-Azhar University is the lead sponsor of 505 studies on the registry; 167 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. All patients' ages must range from 60-70 years old.
  2. All patients' ridges should be covered with firm mucosa free from any signs of inflammation or ulceration and exhibit adequate height and width of the residual alveolar ridge.
  3. Patients should be free from any metabolic or bone disorder that contraindicate implant installation.
  4. All patients must have sufficient inter arch space

Exclusion criteria

Exclusion Criteria:

  1. Patients with oral or systemic diseases.
  2. Patients with xerostomia or excessive salivation.
  3. Patients with parafunctional habits (bruxism or clenching).
  4. Heavy smoker or alcoholic patients.
  5. Patients with history of temporo-mandibular dysfunction.
  6. Patients with brain disorders or psychiatric disorders
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
26 participants (actual)

Study arms

  • Active comparator
    OT-Equator Attachment

    On the 2nd Stage, implants will be loaded with OT-Equator Attachment to retain overdenture

    Procedure: OT-Equator Attachment

  • Experimental
    Novaloc Attachment

    On the 2nd Stage, implants will be loaded with Novaloc Attachment to retain overdenture

    Procedure: Novaloc Attachment

Interventions

  • ProcedureOT-Equator Attachment

    Two implants will be restored using OT attachment systems, with the mandibular denture retained over these attachments through corresponding metal housing

  • ProcedureNovaloc Attachment

    Two implants will be restored using Novaloc attachment systems, with the mandibular denture retained over these attachments through corresponding metal housing

06

What researchers measure

Primary outcomes

  1. Retention

    it will be measured using digital force gauge

    Time frame: It will be measured at denture insertion, 6 months and 12 months

Secondary outcomes

  1. The Oral Health Impact Profile (OHIP) questionnaire

    It is one of the most technically sophisticated instruments used for assessment of OHRQoL. The OHIP was developed and validated by Slade and Spencer and several versions of the tool have been developed thereafter. Among the available short versions, the OHIP-EDENT has been deemed the most appropriate tool for the edentulous patients, as it presented a set of specific questions. The tool detects the impact of oral health on the quality of life of patients with implant supported overdenture prosthesis, before and after they have received them.

    Time frame: It will be measured at denture insertion, 6 months and 12 months

  2. Patient Satisfaction

    Patient satisfaction was evaluated with a standard 5-point Likert scale questionnaire, which included subjective parameters such as initial adaptability, post insertion problems, aesthetics, masticatory ability, speech, retention. Patients were asked to respond to question given in the questionnaire

    Time frame: it will be measured at denture insertion, 6 month, and 12 month later.

07

Study locations

1 site
  • Oral and Dental Research Institute, National Research Center
    Cairo, Cairo Governorate 4470351, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — Study Protocol and Clinical Study Report

Supporting information: Study protocol, Csr

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07513155
Lead sponsor
Al-Azhar University
Responsible party
Noha Taha Kamel Taha Alloush (Lecturer, Misr International University) — Principal investigator
First posted
Apr 6, 2026
Start date
Apr 1, 2024
Primary completion
Oct 1, 2024
Completion
Oct 1, 2025
Last update
Apr 6, 2026

Study contacts

Noha T Alloush, Lecturer
principal investigator · Misr International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion